Navamedic ASA: Amended cash offer to acquire Sensidose AB and acquisition of shares in Sensidose AB
Oslo, 22 April 2023 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and provider of high-quality products to hospitals…
2,045€
0,49%
Echtzeit-Aktienkurs Navamedic ASA
Bid:
Ask:
Nachrichten zur Navamedic ASA Aktie
Navamedic completes the offer, has entered into agreements to acquire approximately 56.7 per cent of the shares in Sensidose and increases the consideration to SEK 8 in cash per share
This announcement is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand, Singapore, South…
Navamedic announces $7.2m cash offer for Sensidose acquisition
The independent bid committee of Sensidose has recommended the cash offer. At present, the shares of Sensidose are listed on…
Navamedic ASA: Recommended cash offer to acquire Sensidose for approximately SEK 75 million
OSLO, Norway, March 29, 2023 /PRNewswire/ -- Navamedic ASA (OSE: NAVA), a Nordic pharma company and provider of high-quality products…
Navamedic ASA: Recommended cash offer to acquire Sensidose for approximately SEK 75 million
Oslo, 29 March 2023 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and provider of high-quality products to hospitals…
Navamedic ASA: Q4 2022 financial results
OSLO, Norway, Feb. 16, 2023 /PRNewswire/ -- Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality…
Navamedic ASA: Invitation to 2022 4th quarter presentation
OSLO, Norway, Feb. 13, 2023 /PRNewswire/ -- Navamedic ASA (OSE: NAVA) will be presenting its fourth quarter 2022 results on…
Navamedic ASA: Invitation to 2022 4th quarter presentation
Oslo, February 13, 2023 - Navamedic ASA (OSE: Nava) will be presenting its fourth quarter 2022 results on Thursday February…